These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20118465)

  • 1. Pharmacotherapy for borderline personality disorder: NICE guideline.
    Kendall T; Burbeck R; Bateman A
    Br J Psychiatry; 2010 Feb; 196(2):158-9. PubMed ID: 20118465
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacotherapy for patients with borderline personality disorder.
    Gunderson JG
    Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacotherapy for patients with borderline personality disorder.
    Goldberg SC; Schulz SC
    Arch Gen Psychiatry; 1988 Feb; 45(2):195-6. PubMed ID: 2892479
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
    Benjaminsen S
    Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacotherapy in the treatment of borderline personality disorder].
    Alliani D; Tarantelli S
    Riv Psichiatr; 2009; 44(6):357-73. PubMed ID: 20218215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borderline states: pharmacotherapy and psychobiology of personality. A discussion of Soloff's article.
    Rosenberg R
    Acta Psychiatr Scand Suppl; 1994; 379():56-60. PubMed ID: 7912036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotics and borderline personality disorder.
    Adil J
    Br J Psychiatry; 2010 Apr; 196(4):332; author reply 332. PubMed ID: 20357314
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aiming for the standardization of drug therapy for borderline personality disorders].
    Seishin Shinkeigaku Zasshi; 2007; 109(6):572-7. PubMed ID: 17939223
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of UK and US guidelines for drug treatment in borderline personality disorder.
    Tyrer P; Silk KR
    Int Rev Psychiatry; 2011 Aug; 23(4):388-94. PubMed ID: 22026496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Trials for Treatment of Borderline Personality Disorder.
    Schulz SC; Black DW
    Am J Psychiatry; 2015 Aug; 172(8):793. PubMed ID: 26234601
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacotherapy of a 67-year old female with borderline personality disorder].
    Schulkens JEM; Sobczak S; van Alphen SPJ
    Tijdschr Gerontol Geriatr; 2020 Jun; 51(2):. PubMed ID: 32951381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological treatment for patients with borderline personality disorder: practice and study results].
    Schwerthöffer D; Bäuml J; Rentrop M
    Fortschr Neurol Psychiatr; 2013 Aug; 81(8):437-43. PubMed ID: 23939557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Off-label use of atypical antipsychotics in personality disorders.
    Rosenbluth M; Sinyor M
    Expert Opin Pharmacother; 2012 Aug; 13(11):1575-85. PubMed ID: 21933032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
    Friedel RO; Jackson WT; Huston CS; May RS; Kirby NL; Stoves A
    J Clin Psychopharmacol; 2008 Jun; 28(3):345-7. PubMed ID: 18480695
    [No Abstract]   [Full Text] [Related]  

  • 15. Aripiprazole pharmacotherapy of borderline personality disorder.
    Mobascher A; Mobascher J; Schlemper V; Winterer G; Malevani J
    Pharmacopsychiatry; 2006 May; 39(3):111-2. PubMed ID: 16721700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A naturalistic study of changes in pharmacological prescription for borderline personality disorder in clinical practice: from APA to NICE guidelines.
    Pascual JC; Martín-Blanco A; Soler J; Ferrer A; Tiana T; Alvarez E; Pérez V
    Int Clin Psychopharmacol; 2010 Nov; 25(6):349-55. PubMed ID: 20838221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone in comorbid borderline personality disorder and dysthymia.
    Szigethy EM; Schulz SC
    J Clin Psychopharmacol; 1997 Aug; 17(4):326-7. PubMed ID: 9241018
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of outpatients with borderline personality disorder.
    Sweeney DR
    J Clin Psychiatry; 1987 Aug; 48 Suppl():32-7. PubMed ID: 2886495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic treatment in the borderline patient: advantages and techniques.
    Soloff PH
    J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy for borderline personality disorder--current evidence and recent trends.
    Stoffers JM; Lieb K
    Curr Psychiatry Rep; 2015 Jan; 17(1):534. PubMed ID: 25413640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.